Bracco hits Jubilant with patent complaint on rubidium PET

Contrast developer Bracco Diagnostics has filed a complaint against radiopharmaceutical...Read more on AuntMinnie.comRelated Reading: Bracco lands new FDA approval for MultiHance Bracco targets gene therapy for ultrasound contrast Bracco declines comment on Norris gadolinium lawsuit PBS report targets price hike for V/Q radiotracers Jubilant Pharma taps new DraxImage president Jubilant DraxImage, Cyclopharm ink deal
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news